Private label supplements in Europe — a brand founder's playbook

Private label is where brand ownership begins. Unlike white label, where you sell an existing product under your name, private label means you own the formulation. You define the ingredients, the dosages, the delivery format, and the claims. The manufacturer builds it to your specification. The intellectual property — the recipe, the brand, the positioning — is yours.

This is the path for founders who want to build a defensible brand, not just sell a product. It requires more capital, more time, and more involvement. But it produces something that cannot be copied by another brand placing an order from the same catalog. This playbook covers the entire private label journey: from the first decision through development, IP, agreements, and scaling.

What private label actually means

The distinction between white label and private label is often blurred in marketing. Here are the five differences that actually matter:

• Time to market. White label: 4 to 8 weeks. Private label: 4 to 8 months. The difference is the formulation, sampling, stability testing, and registration cycle. If you need product next month, private label is not the answer.
• Upfront investment. White label requires minimal upfront cost beyond the product order. Private label requires R&D fees, sampling rounds, stability testing, regulatory submissions, and often custom packaging tooling. Expect to invest €5,000 to €25,000 before your first production run, depending on complexity.
• Product differentiation. White label products are shared formulas. Private label products are exclusive to you. This is the fundamental tradeoff: speed and low cost versus differentiation and defensibility.
• Scaling economics. White label margins are thinner because the formula is commoditized. Private label margins are wider because you control the cost structure and the competition cannot replicate your exact product. At scale, this difference compounds.
• Brand value at exit. If you ever sell your brand, a private label portfolio with proprietary formulations, documented IP, and exclusive supplier agreements is worth significantly more than a white label catalog that any buyer could replicate in weeks.

When private label is the right commitment

• You have validated demand on white label and want to upgrade. This is the most common entry point. You started with a white label product, proved the market, and now want a formulation that is uniquely yours. You have sales data, customer feedback, and a clear brief for what the custom product should be.
• Your brand promise requires a unique formula. If your positioning is built on a specific ingredient combination, a clinical-dose protocol, or a novel delivery format, you need private label from day one. Selling a generic product while claiming uniqueness erodes trust fast.
• You are entering a competitive category and need differentiation. If the market is crowded with similar products, your formula is one of the few defensible advantages. A unique taste profile, a proprietary blend, or a patented ingredient gives you something to market that competitors cannot match.
• You have the capital and patience for a 6-month development cycle. Private label is not a side project. It requires dedicated attention during the development phase — reviewing formulations, approving samples, making decisions on packaging. If you do not have the bandwidth, wait until you do.
• You want to build a brand that can be acquired or licensed. Acquirers value proprietary IP. A brand with three private label SKUs, documented formulations, and exclusive manufacturing agreements is a fundamentally different asset than a brand reselling catalog products.

The 7-stage development process

Stage 1: Briefing

Everything starts with the brief. You define the product concept: target customer, desired benefits, preferred format (capsule, powder, gummy, sachet, liquid), key ingredients, dosage targets, flavor preferences, and any certifications you need (organic, vegan, allergen-free). A good brief is specific. A bad brief is aspirational. The more precise your brief, the faster the development cycle.

At this stage, you also sign a mutual NDA. This protects both sides: your product concept and the manufacturer's proprietary processes. Do not skip this step, even if the manufacturer says it is unnecessary.

Stage 2: Feasibility and formulation

The R&D team reviews your brief for technical feasibility. Can the ingredients be combined at the dosages you want? Are there stability concerns? Interaction risks? Regulatory limitations? This is where the manufacturer's expertise earns its fee. A good R&D team will push back on unrealistic specifications and propose alternatives that achieve your goals within the constraints of chemistry, regulation, and manufacturing capability.

The output is a paper formulation: a detailed recipe with ingredients, dosages, excipients, and projected costs. You review and approve before any physical work begins.

Stage 3: Sampling

The manufacturer produces bench samples based on the approved formulation. You receive physical product to evaluate: taste, texture, color, dissolution, and overall experience. Most products go through two to four sampling rounds. Each round incorporates your feedback. Capsules are simpler (one to two rounds). Flavored products like gummies or powders typically require three or more rounds to dial in the organoleptic profile.

Stage 4: Stability testing

Once you approve the final sample, stability testing begins. This confirms that the product maintains its quality, potency, and safety over its stated shelf life. Accelerated stability testing (simulating shelf life in compressed time using elevated temperature and humidity) takes 3 to 6 months. Real-time stability runs concurrently but takes 12 to 24 months. Most manufacturers launch on accelerated data and continue real-time monitoring.

Stage 5: Regulatory and compliance

Before production, the product must be registered or notified in each target market. In the EU, this typically means submitting a product notification to the national food authority in each country where you plan to sell. The manufacturer prepares the dossier: ingredient specifications, label text, health claims (EFSA-authorized only), and allergen declarations. This stage can take 2 to 8 weeks depending on the country.

Stage 6: Production

With the formula approved, stability confirmed, and regulatory clearance in hand, the first production batch is manufactured. This is a full-scale production run under EU GMP conditions. Batch records are generated, in-process controls are applied, and the finished product undergoes QA testing. You receive a Certificate of Analysis for every batch. The first production run is typically 2 to 4 weeks from scheduling to finished goods.

Stage 7: Packaging and fulfillment

Labeling, secondary packaging, and palletizing. Your finished goods are shipped to your warehouse, 3PL, or directly to retail. If you have custom packaging (bottles, boxes, sleeves), the tooling was ordered in parallel during Stages 4-5. At this point, your product is market-ready.

The IP framework — who owns what

Intellectual property is where private label relationships get complicated if not defined upfront. Here is what should be explicitly addressed in your agreement:

• The formulation recipe. Who owns it? In most private label arrangements, the brand owns the recipe. But some manufacturers retain ownership and grant you an exclusive license. Clarify this before development starts. If you want portability (the ability to take your recipe to another manufacturer), you need ownership, not a license.
• Brand assets. Your brand name, logo, label designs, and marketing materials are unambiguously yours. This should be stated explicitly in the agreement, even though it seems obvious.
• Manufacturing process IP. The manufacturer's production processes, equipment configurations, and proprietary techniques remain theirs. You do not get access to their process know-how, even if they are making your product.
• Ingredient sourcing relationships. If the manufacturer sources a proprietary or rare ingredient for your product, clarify whether you can access that supplier directly if you change manufacturers. Some ingredients are effectively locked to specific supply chains.
• Stability data. The stability studies conducted on your product — who owns the data? If you move to a different manufacturer, can you use the existing stability data, or do you need to start over? This affects your ability to switch partners.
• Regulatory dossiers. The product notifications and registration documents filed in your name — you should own these. If the manufacturer filed them, ensure you have copies and the right to maintain them independently.
• Tooling and molds. If custom packaging molds or tooling were created for your product, who owns them? Typically, if you paid for the tooling, you own it. But this must be stated in writing.
• Exclusivity periods. Some manufacturers offer formula exclusivity for a defined period (e.g., 24 months). After that, they may use similar formulations for other clients. Negotiate the exclusivity window and understand what happens when it expires.
• Non-compete scope. Can the manufacturer develop a competing product for another client? A narrow non-compete (same formula, same market) is reasonable. A broad non-compete (same category, global) is usually unenforceable and unnecessary.

Negotiating the master agreement

The master supply agreement is the single most important document in your private label relationship. Here are the six clauses that matter most:

• Pricing structure and escalation. Define the unit price at your initial volume, and how pricing changes as volume increases. Include a mechanism for raw material cost adjustments (typically tied to an index or renegotiated quarterly). Avoid agreements where the manufacturer can raise prices unilaterally.
• Minimum order commitments. The manufacturer wants volume certainty. You want flexibility. Find the middle ground: a minimum annual commitment that is achievable based on your current trajectory, with a review mechanism if market conditions change. Overpromising on volume to get a lower price is a common and expensive mistake.
• Quality specifications and rejection rights. Define exactly what constitutes a conforming product: active ingredient tolerances (typically +/- 10% of label claim), microbiological limits, physical attributes (color, odor, dissolution). Specify your right to reject non-conforming batches and the manufacturer's obligation to replace them at no cost.
• Lead times and capacity reservation. Agree on standard lead times for reorders and the process for securing production capacity during peak periods. If your product is seasonal (e.g., vitamin D in winter), ensure the manufacturer can accommodate demand spikes with adequate forward planning.
• Liability and insurance. Who is liable if the product causes harm? In the EU, the responsible food business operator (typically the brand owner) bears primary liability. But your agreement should require the manufacturer to carry product liability insurance and indemnify you against manufacturing defects. Get proof of their insurance annually.
• Termination and transition. How do you exit the relationship? Define the notice period (typically 6 to 12 months), the manufacturer's obligation to fulfill outstanding orders, and your right to access the formulation, regulatory documents, and stability data needed to transition to a new partner. A clean exit clause protects both parties.

Common private label mistakes

• Starting private label before validating demand. The most expensive mistake. You invest €15,000 in development, produce 5,000 units, and discover that the market does not want your product. Validate with white label first. Private label is for scaling what works, not for testing hypotheses.
• Under-specifying the brief. A vague brief ("we want a premium collagen product") leads to months of back-and-forth during formulation. A specific brief ("marine collagen peptides, 10g per serving, unflavored powder, 30-serving pouch, targeting women 30-45, key claim: skin elasticity") gives the R&D team everything they need to start.
• Skipping stability testing. Some founders pressure the manufacturer to skip or shorten stability testing to save time. This creates real risk: a product that degrades before its best-before date damages your brand and can trigger a recall. There are no shortcuts here.
• Not owning the IP explicitly. Handshake agreements on formulation ownership create disputes when the relationship ends. Get it in writing before development starts. If the manufacturer insists on retaining the formulation, understand what that means for your ability to switch partners.
• Over-engineering the first product. Your first private label SKU does not need twelve active ingredients, three patented extracts, and a novel delivery format. Start with a strong, simple formula that you can produce reliably. Complexity increases cost, extends timelines, and multiplies the things that can go wrong.
• Ignoring the packaging timeline. Custom packaging (bottles, boxes, sleeves) has its own lead time, often 6 to 10 weeks for tooling and production. If you wait until the formula is finalized to start packaging development, you add months to your launch. Run packaging design and formulation development in parallel.

Picking the right partner

The manufacturer you choose will shape your product, your timeline, and your margins for years. Here is what to evaluate:

• R&D capability. Do they have in-house food scientists and formulators? Can they show you examples of products they have developed (within NDA constraints)? A manufacturer with strong R&D will challenge your brief, propose improvements, and catch problems before they become expensive.
• Regulatory expertise. EU supplement regulation is complex and varies by country. Your manufacturer should have dedicated regulatory staff who can navigate EFSA claims, country-specific notifications, and labeling requirements across your target markets.
• Production flexibility. Can they produce small batches for your first run and scale to large volumes as you grow? Some manufacturers are optimized for high-volume, low-mix production. Others handle multiple SKUs at varying volumes. Make sure their production model matches your growth trajectory.
• Communication and responsiveness. During the development phase, you will have questions, change requests, and time-sensitive decisions. A manufacturer that takes a week to respond to emails will add months to your timeline. Evaluate responsiveness during the sales process — it only gets worse after you sign.
• Financial stability. Your manufacturer is a long-term partner. If they go bankrupt, your supply chain collapses. Ask about their financial position, their client base diversity, and their capacity utilization. A manufacturer running at 95% capacity with two dominant clients is a risk.

The scaling pattern that works

Year 1: First SKU launch

Develop and launch your first private label product. Focus on getting the formula right, the packaging dialed, and the regulatory submissions complete. Do not try to launch multiple private label SKUs simultaneously. One product, done well, is the foundation.

Year 2: Line extension

Add one to two more SKUs based on customer feedback and sales data from Year 1. These might be flavor variants, format extensions (capsule to powder), or complementary products (sleep + recovery). Leverage the existing manufacturer relationship to accelerate development.

Year 3: Portfolio optimization

You now have a mix of white label (volume, lower margin) and private label (differentiation, higher margin) products. Analyze which SKUs drive profit versus which drive customer acquisition. Prune underperformers. Double down on winners. Consider market expansion beyond your home country.

Year 4: Brand maturity

Your private label products are the core of your brand identity. You may negotiate exclusive ingredient partnerships, explore co-branding opportunities, or license your formulations to other markets. The IP you built in Years 1-3 is now a strategic asset, not just a product line.

Quick FAQ

How long does private label development take from brief to first batch?

Typically 4 to 8 months, depending on the product complexity. Simple capsule formulations with well-known ingredients are faster (4 to 5 months). Flavored gummies or novel combinations take longer (6 to 8 months). The biggest variable is sampling rounds — if you approve the sample quickly, the timeline compresses. If you iterate extensively, it extends.

Can I start with private label without doing white label first?

Yes, but it is riskier. White label lets you validate demand with minimal investment. If you are confident in your market (existing audience, pre-orders, retail commitment), going directly to private label is viable. If you are testing an unproven concept, white label first is the safer path.

What happens if I want to switch manufacturers?

If you own your formulation and regulatory dossiers, you can take them to a new manufacturer. The transition typically takes 3 to 6 months: the new manufacturer needs to conduct their own validation runs, and you may need to update regulatory filings. If you do not own the formulation, you are starting from scratch.

How much should I budget for my first private label product?

Budget €8,000 to €25,000 for development (R&D, sampling, stability, regulatory) plus the cost of your first production run. The production cost depends on volume and format — see the white label cost guide for unit cost ranges. Add €2,000 to €5,000 for custom packaging design and tooling if needed. Total first-year investment for a single SKU: €15,000 to €40,000 is a realistic range.